Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and ...

Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares closed ...

Wells Fargo analyst Vik Chopra has assigned their bullish stance on MASI stock, giving a Buy rating yesterday. Vik Chopra has given his Buy ...

Masimo (MASI) delivered earnings and revenue surprises of 16.67% and 0.40%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

The consensus rating for Masimo is Buy, based on 2 analyst ratings. With an average one-year price target of $167.5, there's a potential 16.14% upside.

The tech giant also allegedly attempted to hire away key employees, including Cercacor’s former chief technology officer and ...

The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 84 cents per share. The medical technology company posted revenue of $504.6 million in the period, also ...

The consensus among analysts is an Outperform trajectory for Inspire Medical Systems ... All You Need to Know About Masimo Masimo Corp is a global technology company. The company's segment ...

Masimo executives are back calling their consumer audio business Sound United, with a senior executive on a conference call ...

IRVINE, California - Masimo (NASDAQ:MASI ... 7.5% as fourth-quarter revenue guidance fell short of estimates. The medical technology company posted adjusted earnings per share of $0.98 for ...